Global Total Internal R&D Personnel in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Units (Full-Time Equivalent))

The analysis of Global Total Internal R&D Personnel in the manufacture of Basic Pharmaceutical Products and Preparations highlighted a diverse distribution across countries for 2023. China led significantly with a share of 61.67%, followed by Japan and Germany with 10.32% and 8.83%, respectively. South Korea also showed noteworthy growth, exhibiting a 6.14% year-on-year increase. The United Kingdom demonstrated considerable positive growth at 12.62%, while New Zealand experienced a significant contraction of -14.73%. Over the last five years, China and South Korea had steady growth, while Japan's and Canada's shares declined.

Looking ahead, trends to watch include emerging market expansions and potential R&D investments in specific regions, particularly in Asia. The increasing demand for innovative pharmaceutical solutions is expected to drive up R&D activities globally, with countries aiming to enhance their share through strategic investments and technological advancements.